FLGT
FLGT
NASDAQ · Health Care

Fulgent Genetics Inc

$19.42
+0.29 (+1.52%)
As of Jun 25, 2:11 PM ET ·
Financial Highlights (FY 2026)
Revenue
297.76M
Net Income
-55,841,303
Gross Margin
40.6%
Profit Margin
-18.8%
Rev Growth
-19.5%
D/E Ratio
0.00
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 40.6% 40.6% 39.4% 39.4%
Operating Margin -31.3% -28.2% 19.5% 19.5%
Profit Margin -18.8% -17.8% 13.5% 13.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 297.76M 369.98M 242.23M 275.80M
Gross Profit 120.77M 150.06M 95.53M 108.77M
Operating Income -93,227,968 -104,255,928 47.17M 53.86M
Net Income -55,841,303 -62,446,785 32.57M 36.27M
Gross Margin 40.6% 40.6% 39.4% 39.4%
Operating Margin -31.3% -28.2% 19.5% 19.5%
Profit Margin -18.8% -17.8% 13.5% 13.2%
Rev Growth -19.5% -19.5% -1.5% -4.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 637.4K 637.4K 257.54M 237.86M
Total Equity 254.97M 254.97M 521.51M 552.15M
D/E Ratio 0.00 0.00 0.49 0.43
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -85,809,639 -101,291,199 59.74M 74.06M
Free Cash Flow 22.63M 30.51M